Reports form ACC 03: Advances in Lipid Management

JUNE 01, 2003
Physicians, nurses, and other health care providers from the United States and around the world gathered in Chicago, March 30 to April 2, 2003, for the 52nd Annual Scientific Session of the American College of Cardiology. Identification of patients at high risk for cardiovascular disease, advances in lipid-lowering therapy, and modification of other cardiovascular risk factors were discussed at symposia and oral and poster sessions. Highlights of these sessions as well as a commentary on the clinical implications of these new findings are presented here.

SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.